BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 29521220)

  • 21. Microphysiological modeling of the reproductive tract: a fertile endeavor.
    Eddie SL; Kim JJ; Woodruff TK; Burdette JE
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1192-202. PubMed ID: 24737736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microfluidic cell culture array chip for drug screening assays].
    Zheng Y; Wu J; Shao J; Jin Q; Zhao J
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):779-85. PubMed ID: 19670650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organs-on-a-chip: a new tool for drug discovery.
    Polini A; Prodanov L; Bhise NS; Manoharan V; Dokmeci MR; Khademhosseini A
    Expert Opin Drug Discov; 2014 Apr; 9(4):335-52. PubMed ID: 24620821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity.
    Diekjürgen D; Grainger DW
    Arch Toxicol; 2019 May; 93(5):1349-1364. PubMed ID: 30863989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
    Nam KH; Smith AS; Lone S; Kwon S; Kim DH
    J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney on chips.
    Lee J; Kim K; Kim S
    Methods Cell Biol; 2018; 146():85-104. PubMed ID: 30037468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity.
    Qu Y; An F; Luo Y; Lu Y; Liu T; Zhao W; Lin B
    Biomaterials; 2018 Feb; 155():41-53. PubMed ID: 29169037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microfluidic organ-on-a-chip models of human liver tissue.
    Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
    Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology.
    Lee SH; Sung JH
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28945001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges.
    Sakolish CM; Esch MB; Hickman JJ; Shuler ML; Mahler GJ
    EBioMedicine; 2016 Mar; 5():30-9. PubMed ID: 27077109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions.
    Bale SS; Borenstein JT
    Drug Metab Dispos; 2018 Nov; 46(11):1638-1646. PubMed ID: 30115643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of hepatic metabolism-dependent nephrotoxicity on an organs-on-a-chip microdevice.
    Li Z; Jiang L; Zhu Y; Su W; Xu C; Tao T; Shi Y; Qin J
    Toxicol In Vitro; 2018 Feb; 46():1-8. PubMed ID: 28986290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research advances of high-throughput cell-based drug screening systems based on microfluidic technique].
    Liang Y; Pan J; Fang Q
    Se Pu; 2021 Jun; 39(6):567-577. PubMed ID: 34227317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidic cell chips for high-throughput drug screening.
    Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
    Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ-on-a-chip platforms for studying drug delivery systems.
    Bhise NS; Ribas J; Manoharan V; Zhang YS; Polini A; Massa S; Dokmeci MR; Khademhosseini A
    J Control Release; 2014 Sep; 190():82-93. PubMed ID: 24818770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-engineered kidney disease models.
    Desrochers TM; Palma E; Kaplan DL
    Adv Drug Deliv Rev; 2014 Apr; 69-70():67-80. PubMed ID: 24361391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents.
    Maschmeyer I; Lorenz AK; Schimek K; Hasenberg T; Ramme AP; Hübner J; Lindner M; Drewell C; Bauer S; Thomas A; Sambo NS; Sonntag F; Lauster R; Marx U
    Lab Chip; 2015 Jun; 15(12):2688-99. PubMed ID: 25996126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung-on-a-chip: the future of respiratory disease models and pharmacological studies.
    Shrestha J; Razavi Bazaz S; Aboulkheyr Es H; Yaghobian Azari D; Thierry B; Ebrahimi Warkiani M; Ghadiri M
    Crit Rev Biotechnol; 2020 Mar; 40(2):213-230. PubMed ID: 31906727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.
    Mohammadi MH; Heidary Araghi B; Beydaghi V; Geraili A; Moradi F; Jafari P; Janmaleki M; Valente KP; Akbari M; Sanati-Nezhad A
    Adv Healthc Mater; 2016 Oct; 5(19):2459-2480. PubMed ID: 27548388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.